We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Non-Invasive 3D Imaging System Enables Physicians to Identify Origin of Arrhythmias Pre-Procedure

By HospiMedica International staff writers
Posted on 02 Dec 2022
Print article
Image: VIVO 3D imaging system is designed for pre-procedure arrhythmia localization (Photo courtesy of Catheter Precision)
Image: VIVO 3D imaging system is designed for pre-procedure arrhythmia localization (Photo courtesy of Catheter Precision)

Conventional invasive mapping for identifying the origin of arrhythmias pre-procedure is both time-consuming for localization and often unsuccessful. Now, a novel localization device is setting a new standard for planning of ventricular ablation procedures by enabling physicians to noninvasively identify an area of ventricular arrhythmia onset.

VIVO from Catheter Precision (Mt. Olive, NJ, USA) is a non-invasive 3D imaging system that enables physicians to identify the origin of arrhythmias pre-procedure, streamlining workflow and reducing overall procedure time. VIVO requires acquisition of a MRI or CT image, a standard 12 lead electrocardiogram (ECG) and a 3D photograph of the patient’s torso with the ECG leads in place. These data are used to create patient specific heart and torso models and to identify precise electrode placement of the 12 lead ECG. Once these data are combined, VIVO uses mathematical algorithms to identify the arrhythmia location on a 3D map of the heart, shown in red. The localization, obtained prior to the procedure, can be used in pre-procedure planning.

The VIVO system is comprised of three pieces of equipment and includes hardware (one time purchase) and a single use disposable component. The VIVO software comes loaded on a laptop PC and includes the 3D camera and required accessories, such as a USB cable. Positioning patches are placed on the patient’s torso to aid in positioning the camera for optimal 3D photograph outcomes. So far, the VIVO system has been used in more than 800 procedures in leading U.S. and European hospitals.

“We are always looking to the next milestone in clinical usage of our VIVO System and reaching 800 procedures by the end of 2022 was a goal we set earlier this year,” said David Jenkins, Catheter Precision CEO. “We are gratified by physician adoption so far through our strategic limited launch and look forward to expanding usage in 2023 by growing our sales and clinical support teams to access additional hospitals in new and existing territories.”

Related Links:
Catheter Precision

Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Hydrogen Peroxide Sterilizer
HMA-30

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.